ProQR Therapeutics N.V. Proceeds From Borrowings Classified As Financing Activities
ProQR Therapeutics N.V. (PRQR) reported Proceeds From Borrowings Classified As Financing Activities of EUR 284.00 thousand for the 3-month period ending 2021-12-31, per its 6-K filed 2022-02-24.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities · last filed 2024-03-13
- ProQR Therapeutics N.V. proceeds from borrowings classified as financing activities for the quarter ending 2021-12-31 was 284.00K EUR.
- ProQR Therapeutics N.V. proceeds from borrowings classified as financing activities for the quarter ending 2021-09-30 was 284.00K EUR.
- ProQR Therapeutics N.V. proceeds from borrowings classified as financing activities for the quarter ending 2021-06-30 was 569.00K EUR, a 96.89% increase year-over-year.
- ProQR Therapeutics N.V. proceeds from borrowings classified as financing activities for the quarter ending 2020-12-31 was 0.00 EUR, a 100.00% decline year-over-year.
| Period end | Proceeds From Borrowings Classified As Financing Activities 3 month | Proceeds From Borrowings Classified As Financing Activities 6 month | Proceeds From Borrowings Classified As Financing Activities 9 month | Proceeds From Borrowings Classified As Financing Activities 12 month |
|---|---|---|---|---|
| 2021-12-31 | 284.00K EUR 6-K · filed 2022-02-24 | 568.00K EUR derived: sum of 2 quarters · filed 2022-11-09 | 1.14M EUR derived: sum of 3 quarters · filed 2022-11-09 | 1.14M EUR 20-F · filed 2024-03-13 |
| 2021-09-30 | 284.00K EUR 6-K · filed 2022-11-09 | 853.00K EUR derived: sum of 2 quarters · filed 2022-11-09 | 853.00K EUR 6-K · filed 2022-11-09 | |
| 2021-06-30 | 569.00K EUR 6-K · filed 2022-08-04 | 569.00K EUR 6-K · filed 2022-08-04 | ||
| 2020-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-03-29 | 0.00 EUR derived: sum of 2 quarters · filed 2023-03-29 | 289.00K EUR derived: sum of 3 quarters · filed 2023-03-29 | 579.00K EUR 20-F · filed 2023-03-29 |
| 2020-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2021-11-04 | 289.00K EUR derived: sum of 2 quarters · filed 2021-11-04 | 579.00K EUR 6-K · filed 2021-11-04 | 2.61M EUR derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | 289.00K EUR 6-K · filed 2021-08-05 | 579.00K EUR 6-K · filed 2021-08-05 | 2.61M EUR derived: sum of 3 quarters · filed 2021-08-05 | |
| 2020-03-31 | 290.00K EUR 6-K · filed 2020-05-07 | 2.32M EUR derived: sum of 2 quarters · filed 2021-02-25 | ||
| 2019-12-31 | 2.03M EUR 6-K · filed 2021-02-25 | 2.03M EUR 20-F · filed 2022-04-29 | ||
| 2018-12-31 | 163.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-24 | 163.00K EUR derived: sum of 2 quarters · filed 2021-03-24 | 264.00K EUR 20-F · filed 2021-03-24 | |
| 2018-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-11-12 | 101.00K EUR 6-K · filed 2019-11-12 | ||
| 2018-06-30 | 101.00K EUR 6-K · filed 2019-08-07 | |||
| 2017-12-31 | 301.00K EUR 20-F · filed 2020-03-31 | |||
| 2017-06-30 | 101.00K EUR 6-K · filed 2018-08-08 | 101.00K EUR 6-K · filed 2018-08-08 | ||
| 2016-12-31 | 370.00K EUR 20-F · filed 2019-03-28 | |||
| 2015-12-31 | 1.64M EUR 20-F · filed 2018-03-30 |